ProPhase Labs, Inc. — Director's Dealing 2015

Dec 8, 2015

SEC Form 4/A — Form 4/A

Issuer: ProPhase Labs, Inc. (PRPH)
CIK: 0000868278
Period of Report: 2015-11-24

Reporting Person: Leventhal Mark S (Director)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2015-11-24	Common Stock, par value $0.0005	P	18500	$1.30	Acquired	850480	Direct
2015-11-25	Common Stock, par value $0.0005	P	17252	$1.30	Acquired	867732	Direct

Footnotes

F1: This amended filing is being made to change the transaction code from the original "A" designation to a "P" designation to align with the description of the transactions disclosed in the original Form 4 filings as filed on November 25, 2015.

F2: The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $1.27 to $1.34, inclusive.

F3: The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $1.27 to $1.33, inclusive.